The Valley Desk

ReviewRMD openPublished

Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective

12 of 37 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Review
Venue
RMD open
Published
Subject terms
T-Lymphocytes; Humans; Lupus Erythematosus, Systemic; Immunotherapy, Adoptive; Receptors, Chimeric Antigen; T-lymphocytes; Lupus nephritis; Lupus erythematosus, systemic; Clinical Trial; Biological Therapy
PubMed ID
41052891
PubMed Central ID
PMC12506445
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal